A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
To compare disease-free survival in patients 60 years or older with acute myeloid leukemia (AML) who are randomly assigned to receive either OCV-501 monotherapy or placebo.
Epistemonikos ID: beed0f8db582b1622497e9c3e007c0dd0833dd99
First added on: Jan 21, 2022